Recruitment Complete
Sponsor ID
20190009

Study to Compare AMG 510 "proposed INN sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

Sponsor ID
20190009
Clinicaltrials.gov ID
NCT04303780
EUCTIS ID
2023-508214-42-00
EudraCT ID
N/A

Study Details

A Phase 3 Study to Compare AMG 510 with Docetaxel in Non Small Cell Lung Cancer (NSCLC) subjects with KRAS p. G12c mutation

Additional Study Details

Phase
Phase 3
Product
AMG 510
Type
Interventional
Masking
None (Open Label)
Enrollment
345
Additional Study Details

Protocol Summary

Primary Outcome Measures

Progression-free survival (PFS)

Timeframe: Baseline to approximately 6 years

Secondary Outcome Measures

Overall Survival (OS)

Timeframe: Baseline to approximately 6 years

Objective Response Rate (ORR)

Timeframe: Baseline to approximately 6 years

Patient Reported Outcomes (PRO)

Timeframe: Baseline to week 12

Quality of Life Assessment

Timeframe: Baseline to week 12

Duration of response (DOR)

Timeframe: Baseline to approximately 6 years

Time to response (TTR)

Timeframe: Baseline to approximately 6 years

Disease control rate (DCR)

Timeframe: Baseline to approximately 6 years

Number of subjects with Clinically significant changes in vital signs

Timeframe: Approximately 1 year

Number of subjects with treatment-emergent adverse events

Timeframe: Estimated up to approximately 6 years

Number of subjects with Clinically significant changes in Laboratory tests

Timeframe: Estimated up to approximately 1 year

Number of Subjects with treatment-related adverse events

Timeframe: Estimated up to 6 years

Maximum plasma concentration (Cmax)

Timeframe: Estimated up to 4 months

Area under the plasma concentration-time curve (AUC)

Timeframe: Estimated up to 4 months

Locations

Location
Status
Contact Us
Location
Centre Hospitalier Universitaire de Liege
Liege, Belgium, 4000
Status
Recruiting
Location
Metropolitan Hospital
Athens, Greece, 18547
Status
Recruiting
Location
Nederlands Kanker Instituut Antoni van Leeuwenhoekziekenhuis
Amsterdam, Netherlands, 1066 CX
Status
Recruiting
Location
Center for Oncology Clinical Trials
Grand Rapids, MI, United States, 49503
Status
Recruiting
Location
Miyagi Cancer Center
Natori-shi, Miyagi, Japan, 981-1293
Status
Recruiting
Location
Erasmus Medisch Centrum
Rotterdam, Netherlands, 3015 GD
Status
Recruiting
Showing {first} - {last} of {total} Results